TegoScience Inc. (KOSDAQ:191420)
South Korea
· Delayed Price · Currency is KRW 12,510
-150 (-1.18%)
At close: Apr 28, 2026
TegoScience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 5,941 | 6,759 | 7,772 | 7,678 | 8,300 | Upgrade
|
| Other Revenue | -0 | -0 | - | -0 | -0 | Upgrade
|
| Revenue | 5,941 | 6,759 | 7,772 | 7,678 | 8,300 | Upgrade
|
| Revenue Growth (YoY) | -12.11% | -13.04% | 1.23% | -7.49% | -5.57% | Upgrade
|
| Cost of Revenue | 1,936 | 1,998 | 2,496 | 2,078 | 1,936 | Upgrade
|
| Gross Profit | 4,005 | 4,761 | 5,277 | 5,600 | 6,364 | Upgrade
|
| Selling, General & Admin | 3,055 | 3,392 | 3,584 | 3,554 | 3,802 | Upgrade
|
| Research & Development | 5,065 | 2,663 | 2,576 | 1,608 | 2,328 | Upgrade
|
| Amortization of Goodwill & Intangibles | 28.79 | 27.69 | 27.78 | 31.93 | 31.83 | Upgrade
|
| Other Operating Expenses | 56.13 | 69.13 | 62.85 | 62 | 58.23 | Upgrade
|
| Operating Expenses | 8,429 | 7,367 | 6,461 | 5,370 | 6,462 | Upgrade
|
| Operating Income | -4,424 | -2,606 | -1,185 | 229.63 | -98.01 | Upgrade
|
| Interest Expense | -1,252 | -89.77 | -62.39 | -35.48 | -16.53 | Upgrade
|
| Interest & Investment Income | 1,208 | 895.97 | 813.49 | 572.17 | 250.31 | Upgrade
|
| Currency Exchange Gain (Loss) | 102.31 | 23.88 | -51.51 | -0.46 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -3,602 | 469.55 | 179.12 | 15.18 | 15.48 | Upgrade
|
| EBT Excluding Unusual Items | -7,968 | -1,307 | -306.01 | 781.04 | 151.26 | Upgrade
|
| Gain (Loss) on Sale of Investments | -139.15 | 4,145 | -1,115 | -579.44 | -85.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.28 | -0 | -0 | -0 | - | Upgrade
|
| Asset Writedown | - | - | -1,142 | - | - | Upgrade
|
| Pretax Income | -8,107 | 2,839 | -2,563 | 201.59 | 66.21 | Upgrade
|
| Income Tax Expense | -1,087 | -477.5 | -219.74 | -54.41 | 18.67 | Upgrade
|
| Earnings From Continuing Operations | -7,021 | 3,316 | -2,343 | 256.01 | 47.55 | Upgrade
|
| Minority Interest in Earnings | 8.14 | 33.48 | 20.54 | 8.5 | 91.71 | Upgrade
|
| Net Income | -7,012 | 3,350 | -2,323 | 264.51 | 139.26 | Upgrade
|
| Net Income to Common | -7,012 | 3,350 | -2,323 | 264.51 | 139.26 | Upgrade
|
| Net Income Growth | - | - | - | 89.95% | -92.40% | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | - | - | -0.02% | -0.43% | -0.16% | Upgrade
|
| EPS (Basic) | -875.83 | 418.36 | -290.08 | 33.03 | 17.31 | Upgrade
|
| EPS (Diluted) | -876.00 | 418.00 | -290.08 | 33.00 | 17.00 | Upgrade
|
| EPS Growth | - | - | - | 94.12% | -92.51% | Upgrade
|
| Free Cash Flow | -3,116 | -1,196 | -830.74 | 1,025 | 441.05 | Upgrade
|
| Free Cash Flow Per Share | -389.20 | -149.40 | -103.76 | 127.97 | 54.84 | Upgrade
|
| Gross Margin | 67.41% | 70.44% | 67.89% | 72.93% | 76.68% | Upgrade
|
| Operating Margin | -74.48% | -38.56% | -15.24% | 2.99% | -1.18% | Upgrade
|
| Profit Margin | -118.04% | 49.56% | -29.88% | 3.45% | 1.68% | Upgrade
|
| Free Cash Flow Margin | -52.45% | -17.70% | -10.69% | 13.35% | 5.31% | Upgrade
|
| EBITDA | -3,874 | -2,067 | -637.63 | 811.02 | 490.7 | Upgrade
|
| EBITDA Margin | -65.21% | -30.58% | -8.20% | 10.56% | 5.91% | Upgrade
|
| D&A For EBITDA | 550.43 | 539.53 | 547.11 | 581.39 | 588.71 | Upgrade
|
| EBIT | -4,424 | -2,606 | -1,185 | 229.63 | -98.01 | Upgrade
|
| EBIT Margin | -74.48% | -38.56% | -15.24% | 2.99% | -1.18% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 28.19% | Upgrade
|
| Advertising Expenses | 181.71 | 363.39 | 450.76 | 521.39 | 873.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.